Management of Factor Xa inhibitor-associated life-threatening major hemorrhage: A retrospective multi-center analysis

This publication has 26 references indexed in Scilit:

• Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding
  Circulation, 2013
• A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa
  Nature Medicine, 2013
• Guidelines for the Early Management of Patients With Acute Ischemic Stroke
  Stroke, 2013
• Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors
  American Journal of Hematology, 2012
• Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban
  Thrombosis and Haemostasis, 2012
• Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
  Circulation, 2011
• Apixaban versus Warfarin in Patients with Atrial Fibrillation
  New England Journal of Medicine, 2011
• Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
  New England Journal of Medicine, 2011
• Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
  American Journal of Epidemiology, 2011
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
  Journal of Thrombosis and Haemostasis, 2005